Literature DB >> 23831756

Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration.

Dayong Lee1, Ryan Vandrey, Garry Milman, Mateus Bergamaschi, Damodara R Mendu, Jeannie A Murray, Allan J Barnes, Marilyn A Huestis.   

Abstract

Oral fluid (OF) is a valuable biological alternative for clinical and forensic drug testing. Evaluating OF to plasma (OF/P) cannabinoid ratios provides important pharmacokinetic data on the disposition of drug and factors influencing partition between matrices. Eleven chronic cannabis smokers resided on a closed research unit for 51 days. There were four 5-day sessions of 0, 30, 60, and 120 mg oral ∆(9)-tetrahydrocannabinol (THC)/day followed by a five-puff smoked cannabis challenge on Day 5. Each session was separated by 9 days ad libitum cannabis smoking. OF and plasma specimens were analyzed for THC and metabolites. During ad libitum smoking, OF/P THC ratios were high (median, 6.1; range, 0.2-348.5) within 1 h after last smoking, decreasing to 0.1-20.7 (median, 2.1) by 13.0-17.1 h. OF/P THC ratios also decreased during 5-days oral THC dosing, and after the smoked cannabis challenge, median OF/P THC ratios decreased from 1.4 to 5.5 (0.04-245.6) at 0.25 h to 0.12 to 0.17 (0.04-5.1) at 10.5 h post-smoking. In other studies, longer exposure to more potent cannabis smoke and oromucosal cannabis spray was associated with increased OF/P THC peak ratios. Median OF/P 11-nor-9-carboxy-THC (THCCOOH) ratios were 0.3-2.5 (range, 0.1-14.7) ng/μg, much more consistent in various dosing conditions over time. OF/P THC, but not THCCOOH, ratios were significantly influenced by oral cavity contamination after smoking or oromucosal spray of cannabinoid products, followed by time-dependent decreases. Establishing relationships between OF and plasma cannabinoid concentrations is essential for making inferences of impairment or other clinical outcomes from OF concentrations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23831756      PMCID: PMC3758774          DOI: 10.1007/s00216-013-7159-8

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  31 in total

1.  Disposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration.

Authors:  Garry Milman; Allan J Barnes; David M Schwope; Eugene W Schwilke; William D Darwin; Robert S Goodwin; Deanna L Kelly; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chem       Date:  2010-06-08       Impact factor: 8.327

Review 2.  Extent of illicit drug use and dependence, and their contribution to the global burden of disease.

Authors:  Louisa Degenhardt; Wayne Hall
Journal:  Lancet       Date:  2012-01-07       Impact factor: 79.321

Review 3.  Current technologies and considerations for drug bioanalysis in oral fluid.

Authors:  E Gallardo; M Barroso; J A Queiroz
Journal:  Bioanalysis       Date:  2009-06       Impact factor: 2.681

4.  Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration.

Authors:  David M Schwope; Erin L Karschner; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chem       Date:  2011-08-11       Impact factor: 8.327

5.  Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration.

Authors:  Erin L Karschner; W David Darwin; Robert S Goodwin; Stephen Wright; Marilyn A Huestis
Journal:  Clin Chem       Date:  2010-11-15       Impact factor: 8.327

6.  Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.

Authors:  Dayong Lee; Garry Milman; Allan J Barnes; Robert S Goodwin; Jussi Hirvonen; Marilyn A Huestis
Journal:  Clin Chem       Date:  2011-06-15       Impact factor: 8.327

7.  Pharmacokinetic properties of delta9-tetrahydrocannabinol in oral fluid of occasional and chronic users.

Authors:  Stefan W Toennes; Johannes G Ramaekers; Eef L Theunissen; Manfred R Moeller; Gerold F Kauert
Journal:  J Anal Toxicol       Date:  2010-05       Impact factor: 3.367

Review 8.  Testing for cannabis in the work-place: a review of the evidence.

Authors:  Scott Macdonald; Wayne Hall; Paul Roman; Tim Stockwell; Michelle Coghlan; Sverre Nesvaag
Journal:  Addiction       Date:  2010-03       Impact factor: 6.526

9.  Drug violations and aviation accidents: findings from the US mandatory drug testing programs.

Authors:  Guohua Li; Susan P Baker; Qi Zhao; Joanne E Brady; Barbara H Lang; George W Rebok; Charles DiMaggio
Journal:  Addiction       Date:  2011-04-07       Impact factor: 6.526

Review 10.  Cannabis effects on driving skills.

Authors:  Rebecca L Hartman; Marilyn A Huestis
Journal:  Clin Chem       Date:  2012-12-07       Impact factor: 8.327

View more
  5 in total

1.  Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers.

Authors:  Sebastien Anizan; Garry Milman; Nathalie Desrosiers; Allan J Barnes; David A Gorelick; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2013-08-17       Impact factor: 4.142

2.  Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationships.

Authors:  Rebecca L Hartman; Timothy L Brown; Gary Milavetz; Andrew Spurgin; David A Gorelick; Gary Gaffney; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2015-08-10       Impact factor: 3.345

3.  Development and validation of a solid-phase extraction method using anion exchange sorbent for the analysis of cannabinoids in plasma and serum by gas chromatography-mass spectrometry.

Authors:  Angela Gasse; Heidi Pfeiffer; Helga Köhler; Jennifer Schürenkamp
Journal:  Int J Legal Med       Date:  2016-04-12       Impact factor: 2.686

Review 4.  Cannabis and Its Secondary Metabolites: Their Use as Therapeutic Drugs, Toxicological Aspects, and Analytical Determination.

Authors:  Joana Gonçalves; Tiago Rosado; Sofia Soares; Ana Y Simão; Débora Caramelo; Ângelo Luís; Nicolás Fernández; Mário Barroso; Eugenia Gallardo; Ana Paula Duarte
Journal:  Medicines (Basel)       Date:  2019-02-23

5.  US Epidemiology of Cannabis Use and Associated Problems.

Authors:  Deborah S Hasin
Journal:  Neuropsychopharmacology       Date:  2017-08-30       Impact factor: 7.853

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.